Answers are grounded in this paper and cite their sources.
Surgical treatment of renal cell carcinoma is the gold standard. Nephron-sparing surgery, laparoscopic and robotic surgery and minimally invasive procedures have decreased the morbidity of treatment. Although traditionally resistant to chemotherapy and radiation therapy, advances have been made with immunotherapies. Physicians and nurses caring for patients with renal cell carcinoma should be aware of changes in management and newer therapies for treatment of advanced disease.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: